Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1

被引:2
|
作者
Li, Mao [1 ]
Wang, Zhanjun [2 ]
Cui, Fang [1 ]
Yang, Fei [1 ]
Wang, Hongfen [1 ]
Huang, Xusheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myotonic dystrophy type 1; MIRS; multisystemic impairment; cataract; hypogonadism; cardiac abnormalities; QUALITY-OF-LIFE; CTG REPEAT; INVOLVEMENT; PREVALENCE; DISABILITY; FEATURES; COHORT; DEATH; AGE;
D O I
10.3389/fneur.2020.00277
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in patients with DM1, to improve the management of the disease. Methods: To analyze the prevalence and pairwise relationships between various organs involved, we performed a retrospective study by reviewing demographic and clinical information of DM1 patients including age, disease duration, clinical history, muscular impairment rating scale score (MIRS), results of blood biochemistry, electrocardiogram, echocardiography, and ophthalmologic examination. Results: Ninety three DM1 patients (60 males and 33 females), aged 34.7 +/- 12.6 (mean +/- standard deviation) years were recruited. Of which, two congenital cases were of maternal and paternal inheritance, respectively. In the other 91 patients, cataract was found in 44.1% of patients, followed by hypogonadism (40.8%), frontal balding (40.7%), and cardiac abnormalities (34.5%). Thyroid dysfunction and insulin insensitivity were relatively uncommon. Age (p < 0.001) is independently correlated with cataract, and MIRS correlates positively with cardiac abnormalities (p = 0.005) and frontal balding (p = 0.015). Male patients more frequently had frontal balding (Risk ratio, 3.98; 95% confidence interval, 1.493-10.611) compared with female patients. Male patients with cataract presented more frequent cardiac abnormalities (Risk ratio, 4.40; 95% confidence interval, 1.055-18.358) compared with non-cataract male patients. Hypogonadism in male patients was characterized as decreased testosterone level, accompanied by elevated levels of luteinizing hormone and follicle-stimulating hormone. Conclusions: In Chinese patients with DM1, we conclude that (1) cataract, hypogonadism, frontal balding and cardiac abnormalities are frequently observed; (2) age is an independent indicator to cataract and MIRS is the only predictor for cardiac abnormalities and frontal balding; (3) a positive correlation between ophthalmologic and cardiac impairments in male patients is found; (4) endocrine abnormalities show diverse manifestations and hormone tests are recommended; (5) particular attention should be given to patients with older age and higher MIRS score.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1
    Zhong, Huahua
    Zeng, Li
    Yu, Xuefan
    Ke, Qing
    Dong, Jihong
    Chen, Yan
    Luo, Lijun
    Chang, Xueli
    Guo, Junhong
    Wang, Yiqi
    Xiong, Hui
    Liu, Rongrong
    Liu, Changxia
    Wu, Jibao
    Lin, Jie
    Xi, Jianying
    Zhu, Wenhua
    Tan, Song
    Liu, Fuchen
    Lu, Jiahong
    Zhao, Chongbo
    Luo, Sushan
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [42] Disease burden of myotonic dystrophy type 1
    Landfeldt, Erik
    Nikolenko, Nikoletta
    Jimenez-Moreno, Cecilia
    Cumming, Sarah
    Monckton, Darren G.
    Gorman, Grainne
    Turner, Chris
    Lochmueller, Hanns
    JOURNAL OF NEUROLOGY, 2019, 266 (04) : 998 - 1006
  • [43] Noninvasive Home Mechanical Ventilation in Adult Myotonic Dystrophy Type 1: A Systematic Review
    Vosse, Bettine A. H.
    Seijger, Charlotte
    Cobben, Nicolle
    van Engelen, Baziel
    van Kuijk, Sander M. J.
    Faber, Catharina
    Wijkstra, Peter
    RESPIRATION, 2021, 100 (08) : 816 - 825
  • [44] Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis
    Gutschmidt, K.
    Wenninger, S.
    Montagnese, F.
    Schoser, B.
    JOURNAL OF NEUROLOGY, 2021, 268 (02) : 484 - 492
  • [45] Pain in patients with myotonic dystrophy type 2: A postal survey in finland
    Suokas, Kimmo I.
    Haanpaa, Maija
    Kautiainen, Hannu
    Udd, Bjarne
    Hietaharju, Aki J.
    MUSCLE & NERVE, 2012, 45 (01) : 70 - 74
  • [46] Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2
    Krieger, Britta
    Schneider-Gold, Christiane
    Genc, Erhan
    Guentuerkuen, Onur
    Prehn, Christian
    Bellenberg, Barbara
    Lukas, Carsten
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5525 - 5540
  • [47] An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
    Joosten, Isis B. T.
    Janssen, Cheyenne E. W.
    Horlings, Corinne G. C.
    den Uijl, Dennis
    Evertz, Reinder
    van Engelen, Baziel G. M.
    Faber, Catharina G.
    Vernooy, Kevin
    EUROPACE, 2023, 25 (01): : 156 - 163
  • [48] Body composition and clinical outcome measures in patients with myotonic dystrophy type 1
    Sedehizadeh, Saam
    Brook, J. David
    Maddison, Paul
    NEUROMUSCULAR DISORDERS, 2017, 27 (03) : 286 - 289
  • [49] Milestones of progression in myotonic dystrophy type 1 and type 2
    Hamel, Johanna, I
    McDermott, Michael P.
    Hilbert, James E.
    Martens, William B.
    Luebbe, Elizabeth
    Tawil, Rabi
    Moxley, Richard T.
    Thornton, Charles A.
    MUSCLE & NERVE, 2022, 66 (04) : 508 - 512
  • [50] Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
    Callus, Edward
    Bertoldo, Enrico G.
    Beretta, Maria
    Boveri, Sara
    Cardani, Rosanna
    Fossati, Barbara
    Brigonzi, Elisa
    Meola, Giovanni
    FRONTIERS IN NEUROLOGY, 2018, 9